Journal articleBMC Cancer2019
A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method.
- Journal
- BMC Cancer
- Published
- 26 June 2019
- Citations
- 24
- License
- cc by
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try